Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01070810

Thiamine as a Metabolic Resuscitator in Septic Shock

Sponsor: Beth Israel Deaconess Medical Center

Updated 9 times since 2017 Last updated: Apr 29, 2017 Started: Feb 28, 2010 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01070810, this PHASE1/PHASE2 trial focuses on Septic Shock and remains completed. Sponsored by Beth Israel Deaconess Medical Center, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Feb 2017 — Jul 2017 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center
National Center for Complementary and Integrative Health (NCCIH)
National Institutes of Health (NIH)

Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States